YS Biopharma Co., Ltd. (NASDAQ:YS – Get Free Report) was the recipient of a large growth in short interest during the month of August. As of August 31st, there was short interest totalling 706,300 shares, a growth of 198.5% from the August 15th total of 236,600 shares. Currently, 3.5% of the company’s stock are short sold. Based on an average daily volume of 1,330,000 shares, the days-to-cover ratio is currently 0.5 days.
YS Biopharma Stock Down 2.0 %
YS opened at $0.99 on Thursday. YS Biopharma has a 12-month low of $0.75 and a 12-month high of $12.93. The firm has a market capitalization of $25.49 million, a PE ratio of 1.40 and a beta of -0.38. The company has a 50 day simple moving average of $1.22. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.26 and a current ratio of 1.54.
YS Biopharma (NASDAQ:YS – Get Free Report) last issued its quarterly earnings data on Tuesday, August 15th. The company reported ($0.10) earnings per share for the quarter. The firm had revenue of $24.40 million for the quarter.
Institutional Trading of YS Biopharma
About YS Biopharma
YS Biopharma Co, Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001.
- Five stocks we like better than YS Biopharma
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Is Enbridge Stock Too Cheap to Pass Up Now?
- How to Invest in the Best Canadian Stocks
- 5 Best REIT Alternatives for Passive Real Estate Income
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- 5 Reasons Kroger Should Be On Every Income Investor Watchlist
Receive News & Ratings for YS Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YS Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.